Reagent localization market seen reaching $0.75 billion by 2030

The reagent localization and supply chain resilience market is projected to grow from $0.43 billion in 2025 to $0.75 billion by 2030 as labs and manufacturers seek more reliable sourcing. Rising geopolitical tension, AI-driven planning, and domestic production investments are shaping the market’s expansion.

Why it matters: - Reagent supply chains have become a strategic issue for laboratories, diagnostics, and industrial users that need steady access to critical materials. - The market is expanding as companies and governments try to reduce exposure to geopolitical shocks, pandemics, and logistics disruptions. - The shift could improve continuity in clinical testing, pharmaceutical research, and biotech development.

What happened: - The Business Research Company said the reagent localization and supply chain resilience market is expected to grow from $0.43 billion in 2025 to $0.48 billion in 2026. - The report projects the market will reach $0.75 billion by 2030. - The forecast implies a 11.7% CAGR from 2025 to 2026 and an 11.9% CAGR over the longer forecast period. - The report was published July 6, 2026, from London. - Download a free sample of the report.

The details: - Reagent localization and supply chain resilience means building regional or domestic capabilities to produce, source, and distribute lab and industrial reagents. - The approach is designed to reduce dependence on global supply chains that can be disrupted by conflicts, pandemics, and transport bottlenecks. - The report says historical growth has been driven by repeated supply chain interruptions, geopolitical uncertainty, greater use of diagnostic and molecular biology reagents, and rising pharma and biotech research. - Future growth is expected to come from domestic manufacturing investment, AI-powered supply chain planning, cloud-based reagent tracking, government-private sector collaboration, and sustainable sourcing. - The report highlights regional production, strategic stockpiling, dual-sourcing, public-private partnerships, and stricter quality assurance as major trends. - In 2025, North America held the largest share of the market. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa. - View the full market report.

Between the lines: - Geopolitical tension is the clearest near-term demand driver because it pushes buyers to favor domestic sourcing and reduce foreign dependence. - The report points to geoeconomic confrontation as a key global risk, citing a January 2026 World Economic Forum finding that 18% of respondents saw it as the most likely trigger of a near-term global crisis. - The same WEF finding ranked geoeconomic confrontation as the most severe risk over the next two years, moving up eight places from the prior year. - The market opportunity is not just about resilience; it also reflects a broader move toward more visible, digitally managed, and compliance-heavy supply chains.

What's next: - Domestic reagent manufacturing capacity is likely to expand as buyers seek shorter, safer supply lines. - More suppliers are likely to adopt dual sourcing and inventory buffers to reduce single-point failure risk. - AI planning tools and cloud tracking systems should become more common in reagent logistics and procurement. - Public-private partnerships may play a larger role in emergency preparedness and distribution stability.

The bottom line: - Reagent localization is moving from a risk-management idea to a practical procurement strategy, and the market is projected to nearly double by 2030.